VIROLOGY-EDUCATION
Long COVID - a multisystem condition that significantly burdens individuals and public health, experienced by approximately 10-20 % of people infected by SARS-CoV-2.
Defined by the WHO as a continuation or development of new symptoms three months after initial SARS-COV-2 infection, it is characterized by symptoms persisting for at least two months, majorly impacting the patient's daily life, that cannot be explained by other diagnoses.
Common symptoms include fatigue, breathlessness, and cognitive dysfunction.
Given the complexities of this disease and its medical and societal impact, it is crucial to discuss all recent developments and reflect on the difficulties that patients and caregivers continue to face. This new initiative provides a global platform for this vital cross-disciplinary discussion.
Objectives: Raise awareness, share knowledge, and stimulate discussion
- What do we know about the global prevalence, risk factors, and long-term evolution of long COVID?
-
Spotlight on the underlying mechanisms
Mitochondrial and vascular dysfunction, lingering inflammation, or viral persistence: which mechanisms are at play?
-
What are recent advances in clinical management?
What’s new in symptomatic treatment and rehabilitation guidelines?
Novel insights into the management of neurological, respiratory, and cardiovascular symptoms.
Treating Long COVID in children and teens.
-
Prevention and treatment: What’s on the horizon?
Which options are clinically evaluated?
What do the clinical studies show?
-
Coordination in Care Pathways: What are the challenges?
How to strengthen a patient-centric approach to care.
How to improve the care pathways in the light of what is organized in different countries?
Organizing by global thought leaders:
Dr. Daniel Kuritzkes Brigham and Women's Hospital; Harvard Medical School, United States
Dr. Monica Gandhi University of California, San Francisco, United States
Dr. Dominique Salmon Honorary Professor of University of Paris Cité, France
Dr. Roger Paredes IrsiCaixa AIDS Research Institute, Spain
Dr. Anton Pozniak Chelsea and Westminster Hospital, United Kingdom
Dr. Serena Spudich Yale University, United States
Dr. Jonathan Schapiro National Hemophilia Center, Sheba Medical Center, Israel
Dr. Otavio Berwanger Academic Research Organization, Hospital Israelita Albert Einstein, Brazil
Discover the carefully curated program here.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231017163202/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Curatis discloses Corticorelin as active substance of C-PTBE-0123.5.2025 07:00:00 CEST | Press release
Corticorelin Market Opportunity in Peritumoral Brain Edema (PTBE) expected to exceed USD 1 billion; Strengthens team with Dr. Kirsty Crame and Dr. Timm Trenktrog An epidemiological market study commissioned by Curatis Holding AG (SIX:CURN, “Curatis”) shows that the target patient group is substantially larger than previous estimates. In the US alone, over 150,000 patients suffer from peritumoral brain edema in association with malignant tumors. In previous clinical studies, human corticorelin (C-PTBE-01), demonstrated significant benefits in the treatment of PTBE. “The prospect of developing a potential blockbuster drug with that can contribute significantly to the quality of life of many patients, combined with the potential of maintaining the efficacy of immunotherapies for these patients, is very motivating and exciting,” said Dr. Roland Rutschmann, Curatis CEO. Key statements Corticorelin (hCRH), a 41 amino acid endogenous polypeptide, has demonstrated the ability to positively imp
Merck Showcases Innovation in Advanced Cancers and Rare Tumors at ASCO 202522.5.2025 23:43:00 CEST | Press release
Data from Phase 3 MANEUVER study demonstrating significant improvements in physical function and symptoms in patients with tenosynovial giant cell tumor (TGCT) treated with pimicotinib, to be featured in oral presentationLatest results for potential first-in-class anti-CEACAM5 ADC precemtabart tocentecan (M9140) highlight strong rationale for further development in colorectal cancer (CRC)Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced the presentation of new oncology data across more than 12 tumor types at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31 to June 4 in Chicago. The presentations include the Phase 3 MANEUVER data for potentially best-in-class pimicotinib in the treatment of the rare tumor TGCT, as well as data from both company- and investigator-sponsored studies highlighting the company’s focus on advancing differentiated molecules to tackle some of the most challenging cancers.
Cooperation between Topcon Positioning Systems and Amberg Technologies Ltd.22.5.2025 22:17:00 CEST | Press release
Topcon Positioning Systems and Amberg Technologies Ltd. have initiated a close collaboration to enable interoperability between Topcon’s sensor solutions and Amberg Technologies’ software and hardware platforms for rail and tunnel applications. This marks the first step towards offering fully integrated solutions to our shared customers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250522363239/en/ Luc Le Maire, Senior Vice President, Topcon (left) and Johannes Mueller, CEO, Amberg Technologies. About Topcon Positioning Systems Topcon Positioning Systems is an industry-leading designer, manufacturer and distributor of precision measurement and workflow solutions for the global construction, geospatial and agriculture markets. Topcon Positioning Systems is headquartered in Livermore, California, U.S. (topconpositioning.com, LinkedIn, X, Facebook, Instagram). Its European head office is in Zoetermeer, Netherlands. Topcon Cor
LBT Holdings Ltd. Acquires Gonet Bank & Trust Limited, Introducing Bank of Nassau to Uphold the Finest Traditions of Private Banking22.5.2025 18:29:00 CEST | Press release
LBT Holdings Ltd., in partnership with Gonet SA, is pleased to announce the successful acquisition of Gonet Bank & Trust Limited, a distinguished Bahamas-based private bank formerly owned by Gonet SA. The transaction, which has received full regulatory approval from the Swiss Financial Market Supervisory Authority (FINMA), the Central Bank of The Bahamas (CBOB), and The Securities Commission of The Bahamas (SCB), marks a significant milestone for both organizations. Effective immediately, LBT Holdings Ltd. assumes 100% ownership of Gonet Bank & Trust Limited. As part of this strategic transition, Gonet Bank & Trust Limited will be rebranded as Bank of Nassau 1982 Limited, reflecting its renewed vision and commitment to excellence in private banking and wealth management. This acquisition strengthens the position of all parties in the global financial services sector, enabling expanded service offerings while upholding the highest standards of client-centric banking. Bank of Nassau 1982
Andersen Global indvier medlemsfirmaer i Usbekistan og styrker sin tilstedeværelse i Centralasien22.5.2025 16:34:00 CEST | Pressemeddelelse
Andersen Global styrker sin tilstedeværelse i Centralasien med tilføjelsen af Andersen i Usbekistan, hvilket er en del af den fortsatte udvidelse af organisationens kapaciteter i regionen. Firmaet blev grundlagt i 2009 under navnet Virtus Leo og ledes af den administrerende partner Alisher Zaynutdinov. Siden 2021 har det været samarbejdspartner med Andersen Global. Teamet tilbyder tjenester inden for skatte- og juraforhold inden for en bred vifte af sektorer, herunder overholdelse af skattelovgivningen for selskabser og enkeltpersoner, rådgivning om direkte og indirekte skat, transferpriser, ledelsesrapportering og -analyse, selskabsledelse, konkurrenceret og antitrust, selskabs- og bankret, arbejds- og ansættelsesret, retssager og undersøgelser, fusioner og opkøb, fast ejendom, energi, immaterialret samt familieret. "I kraft af vores professionalisme, gennemsigtighed og evne til at se løsninger samt analytiske tilgang til alle opgaver er vi godt positioneret til at rådgive vores klien
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom